Corvex, Inc. MOVE

11.77 (0.21) (1.75%) as of 25 Sep
Market cap
$378.0M
P/E
0.0×

Insider Decisions

Total sells 1.53
in millions of $
Nov 25 Feb 26 May 26 Aug 26
Buy — — — — — — — — — — — —
Sell — — — 6 — — — — — — — —
Insider Ownership 0.00%

Capital & Financial Ratios

Market Cap 378.00
Revenue 4.44
Net Income (27.65)
Free Cash Flow (20.32)
Net Debt (16.13)
Current Ratio 1.80
Debt/Equity 0.01
P/E ratio 0.00
P/S ratio 6.65
P/B ratio 0.00
Past 5Y EPS Growth 10.24%
This Y EPS Growth 58.60%
Next Y EPS Growth 48.21%
Next 5Y EPS Growth 85.98%
in millions of $

Dividends

Payout Ratio 0.00
Annual Dividend Rate —
Annual Dividend Yield —
total individual payouts
2026 Powerpack
2025 Powerpack
2024 Powerpack
2023 Powerpack
2022 Powerpack
2021 Powerpack
2020 Powerpack
2019 Powerpack
2018 Powerpack
predictions in italic, special payouts not included in total or ratios

Assets vs Liabilities

2023 2024 2025 Q'26
Cash 6 8 3 22
Receivables — — — 2
Inventory 1 2 2 —
Other 1 0 0 —
9 10 5 28
2023 2024 2025 Q'26
Payables 3 2 3 4
ST’ Debt — — 4 —
Other 2 1 1 —
6 3 9 16
in millions of $

Compound Annual Growth

10y 5y 3y
Sales — — —
Cash Flow — 0.00% 0.00%
Earnings — 0.00% 0.00%
Book Value — 0.00% 0.00%

Revenue

Mar Jun Sep Dec Year
’26 1 4 — — —
’25 0 0 0 0 0
in millions of $ · fiscal quarters ending in the months shown

Operating Cash Flow

Mar Jun Sep Dec Year
’26 (4) (5) — — —
’25 (4) (3) (2) (2) (11)
’24 (4) (8) (6) (5) (23)
’23 (6) (8) (7) (5) (26)
’22 (6) (6) (6) (6) (25)
’21 (4) (4) (3) (5) (16)
’20 (2) (2) (4) (3) (11)
in millions of $ · fiscal quarters ending in the months shown

Free Cash Flow

Mar Jun Sep Dec Year
’26 (11) (6) — — —
’25 (4) (3) (2) (2) (11)
’24 (4) (8) (6) (5) (23)
’23 (6) (8) (7) (5) (26)
’22 (6) (6) (6) (6) (25)
’21 (4) (4) (3) (5) (17)
’20 (2) (2) (4) (3) (11)
in millions of $ · fiscal quarters ending in the months shown

EPS

Mar Jun Sep Dec Year
’26 (3.13) (5.12) — — —
’25 (5.35) (3.05) (4.73) (5.88) (21.79)
’24 (14.99) (9.00) (10.60) (6.10) (39.40)
’23 (28.49) (25.49) (26.99) (16.49) (94.45)
’22 (31.48) (31.48) (38.98) (35.98) (137.93)
’21 (151.42) (22.49) (23.99) (28.49) (137.93)
’20 (120.28) (147.93) (165.31) (176.81) (610.33)
fiscal quarters ending in the months shown

Target Price Range

Analyst price targets

Recommendation Rating

1
1Buy 2 3Hold 4 5Sell
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028
— — — — — 296.02 140.28 64.06 20.62 3.44

Analyst estimates 2026–2028

Powerpack
Low Price
— — — — — 822.90 453.98 231.96 93.89 44.11
High Price
— — — — 15 27 34 30 32 38
Employees
— — — — 0 0 0 0 0 0
Revenue/Emp
— — — — — — — — 1 0
Revenue
— — 0.00% 0.00% 0.00% 0.00% 0.00% — (196.84%) (424.94%)
Gross Margin
— — (3) (8) (13) (22) (30) (29) (24) (18)
EBT
— — 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% (2,342.25%) (4,222.86%)
EBT Margin
— 0 (3) (8) (13) (22) (30) (29) (24) (18)
Net Income
— — 0 0 1 1 0 0 0 3
Depreciation
— — 0.00 0.00 0.00 0.00 0.00 0.00 1.68 0.51
Revenue/Sh
— — (0.18) (801.88) (610.33) (137.93) (137.93) (94.45) (39.40) (21.79)
Earnings/Sh
— — (0.10) (783.62) (498.41) (92.26) (113.04) (85.02) (37.43) (13.40)
Cash Flow/Sh
— — 0.00 (1.24) 0.00 (3.22) (0.48) (0.21) (0.01) 0.00
Capex/Sh
— — (0.10) (784.86) (498.41) (95.48) (113.51) (85.23) (37.44) (13.40)
Free CF/Sh
— — 0.09 380.67 (376.73) 186.60 35.93 11.20 12.22 (4.13)
Book Value/Sh
— — 32 0 0 0 0 0 1 1
Shares
— — — — — — — — 0.00 0.00
PE Ratio
— — — — — — — — 0.00 11.89
PS Ratio
— — — — — — — — 3.25 0.00
PB Ratio
— — — — — — — — 0.00 15.54
EV/Sales
— — — — — — — — (0.72) (0.60)
EV/FCF
— — (3) (8) (11) (16) (25) (26) (23) (11)
Op' Cash Flow
— — 0 0 — (1) 0 0 0 —
Capex
— — (3) (8) (11) (17) (25) (26) (23) (11)
FCF
— — 3 4 6 32 7 3 7 (4)
Working Cap'
— — — — 12 — 0 — — 4
Total Debt
— — (3) (4) 6 (34) (11) (6) (8) 2
Net Debt
— — 3 4 (8) 33 8 3 7 (3)
Sh' Equity
— — (338.68%) (349.28%) (366.67%) (111.94%) (122.52%) (258.41%) (228.79%) (216.57%)
ROA
— — 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
ROIC
— — 45.24% 113.63% 72.20% 595.39% (149.24%) (515.36%) (439.23%) (944.19%)
ROE
predictions in italic, sparklines do not include predictions

All 10 years →

Fiscal years to Dec 2025 · latest quarter Jun 2026

Corvex, Inc. peers in Software Infrastructure

Company Market cap P/E Compare
AIOT PowerFleet, Inc. $379.9M 0.0× Compare
ARQQ Arqit Quantum Inc. $383.4M 308× Compare
CINT CI&T Inc. $385.3M 10.2× Compare
GRRR Gorilla Technology Group Inc. $394.5M 0.0× Compare
Company Market cap P/E Compare
BKKT Bakkt Holdings, Inc. $398.0M 0.0× Compare
IIIV i3 Verticals, Inc. $398.3M 37.2× Compare
LSAK Lesaka Technologies, Inc. $356.2M 118× Compare
QIWI QIWI PLC $355.6M 9.1× Compare

All 173 Software Infrastructure stocks →

Corvex, Inc. (MOVE) key facts

  • Corvex, Inc. (MOVE) is a Software Infrastructure company in the Technology sector, listed on Nasdaq.
  • Corvex, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $433,000.00, down 57.3% from fiscal 2024.
  • As of September 25, 2026, MOVE traded at $11.77, a market capitalization of $378.0 million.
  • Return on equity was −944.2% and debt-to-equity 0.01.

Source: company filings (standardised) and stockrow calculations.

Corvex, Inc. (MOVE) Latest News

News by impact score

Fine-tune

22 Sep

4

Activist investor Corvex Management requisitioned a general meeting to elect partner James Gemmel to Whitbread's board, arguing the Costa-owner has underperformed and needs independent scrutiny of its growth plans. Corvex owns about 6.4% of Whitbread (roughly 7% economic interest) and says it is the largest active shareholder, while the board owns about 0.04%. It is not seeking control or a sale. Corvex cites negative total shareholder returns: about -17% over 10 years, -18% over five years, and -22% in the past year, alongside ~£2.6bn spent on growth since 2018 with ~3% EPS growth and a flat dividend; it estimates a further ~£2.5bn capex over five years warrants shareholder representation. Gemmel's experience at Kindred Group and MDU Resources is cited as value-creating. Whitbread must decide whether to call the meeting; Corvex says engagement has been limited. Activist seeking a board seat could meaningfully alter Whitbread's strategy and governance, potentially impacting shareholder value.

31 Aug

4

Corvex, Inc. (MOVE) expands data center capacity fivefold with contracted path to thirteenfold increase. Fivefold data center capacity increase with path to thirteenfold expansion drives major operational growth.

28 Aug

3

Corvex, Inc. (MOVE) appoints Garrett Brams to lead data center infrastructure development. Leadership appointment for data center infrastructure may moderately influence operations and market positioning.

15 Aug

4 transcript

Corvex Inc (MOVE) reported Q2 2026 earnings call highlights centered on AI infrastructure growth and strategic initiatives. AI infrastructure growth and strategic moves indicate major expansion potential in high-demand sector likely to shift company trajectory.

14 Aug

4

Corvex, Inc. (MOVE) reported second quarter 2026 financial results along with a business update. Quarterly results releases and business updates typically drive immediate stock moves and reset valuation expectations for Corvex.

3

Movano reported Q2 financial results and operational updates during its earnings call, covering revenue, net losses, product development timelines, and funding needs for its wearable health technology. Q2 earnings call updates on financials and product plans can shift near-term investor sentiment but rarely alter long-term company trajectory.

4 Aug

4

Corvex signs multi-year NVIDIA Blackwell GPU agreement without additional equity issuance. Multi-year NVIDIA Blackwell GPU deal strengthens Corvex's technological capabilities and financial position without share dilution.

4

MOVE stock rises sharply as Corvex expands its Nvidia Blackwell GPU agreement with a leading AI company. Nvidia Blackwell GPU deal expansion drives major AI revenue growth and market gains for Corvex.

4

Corvex, Inc. (MOVE) signed a multi-year agreement to provide NVIDIA Blackwell GPUs. Multi-year NVIDIA Blackwell GPU supply contract drives major revenue growth and strategic positioning for Corvex.

1 Jul

3

Corvex stockholders approved key governance and capital structure proposals at the 2026 annual meeting. Governance and capital structure approvals can moderately affect financial strategy and corporate oversight.

16 Jun

3

Corvex, Inc. (MOVE) appointed Chance Moreland as CFO to accelerate capital formation and AI infrastructure expansion. CFO appointment targets capital raising and AI expansion with moderately noticeable effects on operations and sentiment.

10 Jun

3

Corvex Inc (MOVE) CMO drives campaign to popularize nuclear fusion technology. CMO promotion of nuclear fusion may raise visibility and moderate investor interest in MOVE operations.

8 Jun

3

Nicholas Donofrio joins Corvex Board of Directors to support scaling secure AI infrastructure and Token Factory launch. Board appointment adds relevant expertise to AI efforts but remains incremental to core trajectory.

2 Jun

4

Warren Buffett's successor commits $10 billion to Alphabet via Corvex Inc (MOVE). Major $10 billion Alphabet investment marks significant strategic move for Corvex (MOVE).

3

A suburban homeowner offers to sell his entire neighborhood for data center development as such facilities increasingly expand into residential areas. Suburban data center expansion creates moderate new site opportunities for MOVE without altering core strategy or financials.

20 May

4

Corvex Inc (MOVE) highlighted strategic AI expansion in its Q1 2026 earnings call despite ongoing financial challenges. Strategic AI expansion represents major move expected to significantly alter company trajectory and investor sentiment.

3 transcript

Movano Inc. (MOVE) held its Q1 2026 earnings call covering quarterly results, operations and forward outlook. Earnings call delivers financial results and guidance that can move near-term sentiment and valuation.

19 May

3

Corvex, Inc. (MOVE) reported Q1 2026 financial results and issued a business update. Quarterly financial results and business updates can moderately affect near-term stock movement and investor views.

24 Mar

5

Corvex announces the closing of an all-stock merger with Movano Inc. (MOVE). Closing an all-stock merger fundamentally redefines Movano's ownership, strategy, and long-term market prospects.

3

Corvex, Inc. announces additional details of a special 35.8% stock dividend for Movano Inc. (MOVE) shareholders of record on March 30, 2026. A large 35.8% stock dividend moderately impacts Movano Inc.'s share count, EPS, liquidity, and investor sentiment without fundamentally altering operations.

19 Mar

5

Corvex announces closing of all-stock merger with Movano Inc. (MOVE). Closing an all-stock merger fundamentally redefines Movano Inc.'s corporate structure, ownership, and long-term prospects.

23 Jan

3

Movano Inc. (MOVE) has been identified as one of the most active stocks in the market, reflecting heightened trading activity and investor interest. The company's recent developments and market performance have contributed to its visibility among investors, indicating potential shifts in market sentiment and engagement with its stock. Increased trading activity suggests a moderately noticeable influence on investor sentiment and market performance.

22 Jan

3

Corvex has secured a long-term deployment of NVIDIA H200 GPUs with an AI-driven provider specializing in high-performance battery technologies. This partnership aims to support production AI workloads, enhancing capabilities in battery technology and potentially impacting the efficiency and performance of related operations. The partnership may enhance operational capabilities but its direct influence on Movano Inc.'s core business remains limited.

14 Dec

3

Medacta Group SA (VTX:MOVE) is gaining attention due to its strong financial prospects, which may be overlooked by investors. The company is positioned well in the market, showing potential for growth and stability, making it a noteworthy consideration for those looking at investment opportunities in the healthcare sector. Strong financial prospects may moderately influence investor sentiment and the company's market positioning.

11 Nov

4

Movano Inc. (MOVE) experienced a significant surge in its stock price, tripling after announcing a partnership focused on artificial intelligence. The deal is expected to enhance the company's product offerings and market position in the health tech sector. Investors are weighing the potential long-term benefits against the volatility typical of penny stocks. Analysts are divided on whether this momentum can be sustained, with some cautioning about the inherent risks associated with such investments. The AI partnership is likely to significantly enhance Movano's competitive positioning and market appeal in the health tech industry.

10 Nov

4

Corvex is set to go public through an all-stock merger with Movano Inc., creating a dedicated platform focused on secure AI infrastructure and high-performance inference. This merger aims to enhance Movano's capabilities in the AI sector, positioning it for growth in a rapidly evolving market. The merger represents a significant strategic move that could enhance Movano's competitive positioning and market presence in the AI infrastructure space.

8 Oct

3

Movano Health has announced a reverse stock split, consolidating its shares to improve its stock price and meet listing requirements. The split ratio is set at 1-for-10, meaning every ten shares will be converted into one share. This move aims to enhance the company's marketability and attract institutional investors. The reverse split is expected to take effect on a specified date, pending regulatory approval. The reverse stock split may improve market perception and attract investors, but its overall impact on long-term performance remains uncertain.

30 Sep

3

Medacta Group (VTX:MOVE) is showing promising return trends, indicating potential growth and positive performance in the market. The company's strategic initiatives and product innovations are contributing to this optimistic outlook, suggesting a favorable trajectory moving forward. Promising return trends may moderately influence Medacta Group's financial performance and competitive positioning.

14 Sep

3

Concerns have been raised regarding the quality of earnings reported by Medacta Group, suggesting potential underlying issues that could affect investor confidence and market perception. Analysts are scrutinizing the financial statements for inconsistencies that may indicate deeper problems within the company's operations. Potential issues with earnings quality could moderately influence investor sentiment and financial performance.

1 Sep

3

Medacta Group SA's share price is currently under scrutiny as it reflects market trends and investor sentiment. The company's performance is influenced by various factors, including recent financial results and market dynamics. Analysts are closely monitoring these developments to gauge potential impacts on future growth and profitability. Market trends and financial results may moderately influence Medacta's competitive positioning and performance.

stockrow.com/MOVE · Data as of Jun 30, 2026 · For information only; not investment advice. · © 2026 stockrow.com